Molecular staging of prostate cancer: Comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer

International Journal of Urology

Volumn 5, Issue 4, 1998, Pages 349-356

  Okegawa, Takatsugu ^a   Yoshioka, Junichi ^b   Morita, Ryoji ^b   Nutahara, Kikuo ^a   Tsukada, Yutaka ^b   Higashihara, Eiji ^a  

^a KYORIN UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

Polymerase chain reaction; Prostate; Prostate specific antigen; Prostate specific membrane antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031658796     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1998.tb00365.x     Document Type: Article

References (30)

1. Boring CC, SquiresTS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994;44:7-26.
2. Shimizu H, Ross RS, Bernstein L. Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn J Cancer Res 1991;82:483-485.
3. Freeman JA, Cook DW, Lieskovsky G, Petrovich Z, Grossfild G, Chen S, Esrig DE, Groshen S, Stein JP, Skinner DG. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate. Urology 1994;44:719-725.
4. Huland H, Hammerer P, Henke R, Huland E. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol 1996;155: 1344-1347.
5. Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barren D, Zinke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J Urol 1996; 155:821-826.
6. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990; 143:538-544.
7. Rowley PT, Farley BA, Labella S, Giuliano R, Leary JF. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens. Int J Cell Cloning 1992;10:232-240.
8. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenyl-chloroform extraction. Anal Biochem 1987;162:156-159.
9. Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, Ploegh HL. The human β-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 1987;139:3132-3138.
10. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Molecular staging of prostate cancer with the use of an enhanced reverse transcription polymerase chain reaction assay. Urology 1994;43:765-775.
11. Katz AE, deVries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, Olsson CA. Enhanced reverse transcription polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995;75:1642-1648.
12. Israeli RS, Miller WH, Jr, Su SL, Samadi DS, Powell CT, Heston WDW, Wise GJ, Fair WR. Sensitive detection of prostatic hematogenous micrometastasis using prostate specific antigen (PSA) and prostate membrane antigen (PSM) derived primers in the polymerase chain reaction. J Urol 1995;153:573-577.
13. Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, De Blasio A, Edwards ET, Wise GJ, Heston WDW. Sensitive detection of nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate specific membrane antigen and prostate specific antigen based assays. Cancer Res 1994;54:6306-6310.
14. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994;12:2634-2639.
15. Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, Katz AE. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcription polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol 1995; 153:1373-1378.
16. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman UH. Detection of prostatic cells in peripheral blood: correlation with serum concentration of prostate specific antigen. Clin Chem 1995;41:182-186.
17. Wood DP Jr, Banks ER, Humphries S, Rangnekar VM. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J Histochem Cytochem 1994;42:505-511.
18. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 1995;13:1195-1200.
19. Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorety F, Figlin RA, Pang S, deKernion J, Belldegrun A. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urology 1996;156: 1560-1566.
20. Loric S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate specific membrane antigen. Clin Chem 1995;41:1698-1704.
21. Israeli RS, Powell CT, Fair WR, Heston WDW. Molecular cloning of a complementary DNA encoding a prostate specific membrane antigen. Cancer Res 1993;53:227-230.
22. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43: 1809-1818.
23. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WDW. Expression of the prostate specific membrane antigen. Cancer Res 1994;54:1807-1811.
24. Fair WR, Israeli RS, Heston WDW. Prostate specific membrane antigen. The Prostate 1997;32:140-148.
25. Olsson CA, deVries GM, Benson MC, Raffo A, Buttyan R, Coma C, O'Toole K, Katz AE. The use of RT-PCR for prostate specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Br J Urology 1996;77:411-417.
26. Katz AE, deVries GM, Olsson CA, Benson MC, Swanton P, Ikeguchi EF, Buttyan R. Molecular staging of genitourinary malignancies. Urology 1996;47:948-958.
27. Gomella LG, Raj GV, Moreno JG. Reverse transcription polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urology 1997; 158:326-337.
28. Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progress following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 1995;50:135-141.
29. Smith RC, Partin AW, Epstein JI, Brendler CB. Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. 1996;156:454-458.
30. Catalona WJ, Smith DS. 5-year tumor recurrence after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-1842.